At NMCC, we aggressively manage cancer and the side effects of the disease and treatment to help patients feel better so they spend more time at home. This method of treatment is called a "medical home," and we're so successful at it that our CEO Dr. Barbara McAneny received a grant to duplicate the process at six clinics across the country. As part of the grant, we offer treatment until 8 p.m. during the week and from 1 to 4 p.m. on weekends so our patients don't seek care in the ER. By extending our hours, we keep patients out of the hospital and at home where they're happy and comfortable.
CD19-Directed CAR T Cells Effective in Management of Relapsed/Refractory Acute Lymphoblastic Leukemia
In a study recently published in The New England Journal of Medicine, doctors have reported achieving sustained remissions in children and adults with relapsed/refractory acute lymphoblast... Continue Reading
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAS-102, a novel agent currently under investigation for the treatment of refractory metastatic colorectal cancer.... Continue Reading
NMCC CEO Dr. Barbara McAneny will speak on Sunday, November 2nd about her leadership of this nationally recognized, innovative health care practice as part of the Albuquerque International Association’s lecture series on global health trends. Read about the event here.
NMCC has been caring for the people of Albuquerque, Gallup, Silver City and Ruidoso, and now we’re open in Las Cruces. We opened this new center because as one of the state’s largest cities, we wanted to be able to deliver the care we are known for across the state and the nation to the people of southern New Mexico.
NMCC’s own Dr. Barbara McAneny has been named chair of the American Medical Association’s board of trustees. She is the co-founder of the New Mexico Cancer Center, and she was re-elected to the board on June 9. The following day the board officially elected Dr. McAneny chair after serving as chair-elect for the past year. As chair, Dr. McAneny will help the 21-member board develop strategic plans to implement policy made by the AMA’s House of Delegates. Read more here.